Compare OSPN & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSPN | ORGO |
|---|---|---|
| Founded | 1991 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.1M | 514.0M |
| IPO Year | 2000 | 2016 |
| Metric | OSPN | ORGO |
|---|---|---|
| Price | $11.36 | $3.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $17.00 | $8.00 |
| AVG Volume (30 Days) | ★ 693.4K | 482.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 4.31% | N/A |
| EPS Growth | ★ 297.30 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $243,179,000.00 | ★ $482,043,000.00 |
| Revenue This Year | $0.69 | $8.14 |
| Revenue Next Year | $1.96 | $6.33 |
| P/E Ratio | $14.66 | ★ N/A |
| Revenue Growth | 3.43 | ★ 11.29 |
| 52 Week Low | $10.17 | $2.61 |
| 52 Week High | $18.13 | $7.08 |
| Indicator | OSPN | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 41.74 |
| Support Level | $11.00 | $3.66 |
| Resistance Level | $12.21 | $5.08 |
| Average True Range (ATR) | 0.45 | 0.18 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 69.23 | 20.83 |
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.